Comments on: Novartis To Slash Sales And Marketing http://www.pharmalot.com/2007/09/novartis-to-slash-sales-and-marketing/ News, Comment and Conversation Fri, 10 Feb 2012 18:56:35 +0000 http://wordpress.org/?v=2.6.2 By: No surprise here http://www.pharmalot.com/2007/09/novartis-to-slash-sales-and-marketing/#comment-22409 No surprise here Thu, 18 Oct 2007 14:47:33 +0000 http://www.pharmalot.com/2007/09/novartis-to-slash-sales-and-marketing/#comment-22409 The writing has been on the wall for a long time at Novartis. One let down after another combined with some bad decisions have finally caught up with Novartis. It was only a matter of time before the growing pains really started to hurt. The writing has been on the wall for a long time at Novartis. One let down after another combined with some bad decisions have finally caught up with Novartis. It was only a matter of time before the growing pains really started to hurt.

]]> By: Ed Silverman http://www.pharmalot.com/2007/09/novartis-to-slash-sales-and-marketing/#comment-19617 Ed Silverman Sun, 16 Sep 2007 23:22:14 +0000 http://www.pharmalot.com/2007/09/novartis-to-slash-sales-and-marketing/#comment-19617 Hi, We have corrected the line about the sales force tally. The force was expanded to between 6,000 and 7,000, not 'by' 6,000 to 7,000, as the first comment above rightly points out. Please note that our post cited Thomson Financial, a wire service that was citing the Swiss newspaper. Nonetheless, we take responsibility and appreciate that Lichtstrasse 35 thought enough to write in. Ed at Pharmalot Hi,
We have corrected the line about the sales force tally. The force was expanded to between 6,000 and 7,000, not ‘by’ 6,000 to 7,000, as the first comment above rightly points out. Please note that our post cited Thomson Financial, a wire service that was citing the Swiss newspaper. Nonetheless, we take responsibility and appreciate that Lichtstrasse 35 thought enough to write in.
Ed at Pharmalot

]]> By: Hypocrisy rules http://www.pharmalot.com/2007/09/novartis-to-slash-sales-and-marketing/#comment-19605 Hypocrisy rules Sun, 16 Sep 2007 20:40:32 +0000 http://www.pharmalot.com/2007/09/novartis-to-slash-sales-and-marketing/#comment-19605 Thw Swiss always move slowly. Ebeling's commentary is part of the process they are going through in setting the whole thing up. Once things are in place they will do the slashing. After all with multiple sales forces in USA, Canada and other countries that sell the very same drug to the very same target doctors, the cutting back is a logical thing to do. For them especially after the failure of several drugs and the latest fiasco with their version of VIOXX. Their drug is completely ineffective at low safe dosage (like thier statin Lescol) but deadly at effective high doses. Prexige will never make it in US and will be withdrawn from other markets. This was supposed to be this Co's mega-drug. Some mega drug just like Zelnorm. Thw Swiss always move slowly. Ebeling’s commentary is part of the process they are going through in setting the whole thing up. Once things are in place they will do the slashing. After all with multiple sales forces in USA, Canada and other countries that sell the very same drug to the very same target doctors, the cutting back is a logical thing to do. For them especially after the failure of several drugs and the latest fiasco with their version of VIOXX. Their drug is completely ineffective at low safe dosage (like thier statin Lescol) but deadly at effective high doses. Prexige will never make it in US and will be withdrawn from other markets. This was supposed to be this Co’s mega-drug. Some mega drug just like Zelnorm.

]]> By: Lichtstrasse 35 http://www.pharmalot.com/2007/09/novartis-to-slash-sales-and-marketing/#comment-19586 Lichtstrasse 35 Sun, 16 Sep 2007 17:22:00 +0000 http://www.pharmalot.com/2007/09/novartis-to-slash-sales-and-marketing/#comment-19586 I watched the webcast and Ebeling said that they would be looking at productivity, but he did not specifically say there would be a reduction in the headcount of the US sales force. The Swiss paper is grossly inaccurate in saying that the sales force was expanded by 6-7,000 in 2006. That is the total number of reps they have in the US. Maybe they expanded FROM 6,000 to 7,000. I watched the webcast and Ebeling said that they would be looking at productivity, but he did not specifically say there would be a reduction in the headcount of the US sales force. The Swiss paper is grossly inaccurate in saying that the sales force was expanded by 6-7,000 in 2006. That is the total number of reps they have in the US. Maybe they expanded FROM 6,000 to 7,000.

]]>